Multiple immune modulatory pathway

"Multiple immune modulatory pathways" is a collective term referring to the network of cellular and molecular signaling routes that actively regulate immune responses, including both innate and adaptive branches. These pathways include, but are not limited to, signaling cascades mediated by cytokines, surface receptors (such as toll-like receptors and co-stimulatory molecules), metabolic regulators (like mTOR and AMPK), and intracellular kinases. They shape immune cell differentiation, proliferation, apoptosis, and effector functions, influencing outcomes in cancer, infection, autoimmunity, and other diseases[1][3][7]. Because the term is not a single, discrete molecular entity, it is not considered an actionable therapeutic target in itself, though it encompasses many such targets as components. The use of this term in a structured target context is incorrect, as it refers to a broad regulatory concept, not a specific molecule or druggable protein. There is no standardized abbreviation or unique alias specific to this aggregate; any attempt to structure information for drug discovery or clinical targeting should focus on the specific, individual molecules/receptors/ дажеpathways of interest rather than this broad term.

Other names

Immune modulation pathwaysImmunomodulatory pathwaysImmune regulatory pathways